BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AmStem International, Inc. Retains Hawk Associates for Strategic Investor Relations


5/24/2010 11:14:15 AM

SAN FRANCISCO, CA--(Marketwire - May 24, 2010) - AmStem International (OTCBB: AMST), an international biotechnology company operating in the high-tech field of stem cell based therapy with emphasis on regenerative medicine and treatments, announced today that it has retained the services of Hawk Associates for strategic investor relations.

David Stark, President of AmStem International, said, "We believe that Hawk Associates is one of the premier investor relations firms helping companies successfully communicate their stories to Wall Street and the broader investment community. We have retained Hawk Associates as a strategic advisor to help us build shareholder value. Hawk specializes in communicating with investors by understanding how to attract attention for small companies like ours. The Wall Street branding and investor relations expertise that Hawk provides will be an excellent complement to our company's initiatives. We look forward to working with Frank Hawkins and his team at Hawk."

Hawk Associates CEO Frank Hawkins said, "AmStem is a leading edge company in one of the most promising new technologies of our time. Unfortunately, it has not had the exposure that it deserves. The acquisition of Histostem in Korea immediately transformed the company into a potential major player in the stem cell area. The company is cleverly using cosmetic sales to avoid the debt and dilution often associated with biotech startups. For investors, this alone sets the company apart from many others in the industry."

"We are looking forward to working with AMST to help build a cohesive branding and messaging strategy that will resonate with investors. This is a unique company with a refreshing story. We are confident we can optimize the company's message and help increase its long-term valuation," Hawkins said.

About AmStem International
AmStem is an international biotechnology company operating in the high-tech field of stem cell-based therapy with emphasis on regenerative medicine and treatments. The company, which operates one of the world's largest cord blood banks, is a pioneer in both medical and cosmetic treatments using stem cells isolated from human umbilical cord blood and nurtured to multipotent stem cells. Actively pursuing new applications in both medicine and cosmetics, AmStem has successfully treated patients with a number of serious diseases and has numerous clinical trials in progress. Its main cosmetic product is the facial cream SteMixx.

An investment profile on AmStem may be found at http://www.hawkassociates.com/profile/amst.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

For more information contact AmStem CFO Andrew Norstrud at (813) 283.2556 or Tom Fox at Hawk Associates at (305) 451.1888. For additional information about AMST visit: http://amsteminc.com or www.hawkassociates.com.


Andrew Norstrud
CFO
AmStem
(813) 283.2556

Tom Fox
Hawk Associates
(305) 451.1888



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES